Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2020-12-16$6.00/sh−2,447$14,682→ 11,094 total
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan.
- [F2]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on each of June 10, 2020 and December 10, 2020.